Skip to main content

The Utilization of a New Yellow Light Laser (578 nm) for the Treatment of Class I Red Telangiectasia of the Lower Extremities

Buy Article:

The full text article is temporarily unavailable.

We apologise for the inconvenience. Please try again later.



A dual-wavelength approach is necessary in order to achieve consistent results when utilizing lasers and intense pulsed light sources to treat red and blue lower extremity vessels. In this regard, short-wavelength technologies (500–800 nm) may be employed to treat red telangiectasia of less than 2 mm on the lower extremities.objective.

To demonstrate a new yellow light laser utilizing a copper bromide medium and its potential efficacy in the treatment of red lower extremity telangiectasia of less than 2 mm.methods.

Forty-six women (mean age 37 years) were treated in two private practice settings with a 578 nm yellow light laser with a circulating cooling window (1–4°C). Class I red telangiectases of the thighs 1.5 mm or less in diameter were considered for treatment. Patients were treated with up to three treatments at 6-week intervals on a 5 cm2 surgical area of vessels utilizing a fluence of 50–55 J/cm2. Results were analyzed by macrophotographic imaging, double-blinded observer evaluation/optical chromatography, and a patient evaluation scale.results.

An average of 1.7 patient treatment sessions produced significant clearing of 75–100% in 71.8% of patients. The mean erythema index showed significant lightening (51–65a+) in the study population. Finally, 76.1% of patients reported great satisfaction with the results of their treatment session.conclusion.

A new 578 nm copper bromide (CuBr) yellow light laser produces excellent results in eradicating red telangiectases of the lower extremities that are less than 2 mm in diameter.

Document Type: Research Article

Publication date: January 1, 2002


Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more